Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Soaring Demand for GentleCure™ Skin Cancer Treatment Reflects Shift Toward Noninvasive Cancer Care

By: NewsUSA

(NewsUSA) - The cancer treatment landscape is undergoing a profound shift. Patients, healthcare providers and advocates are seeking alternatives that deliver both clinical efficacy and quality of life. At the forefront of this movement is GentleCure™, a proven, noninvasive treatment for the most common type of cancer, nonmelanoma skin cancer. 

 

Dermatologists nationwide are reporting a surge in patient awareness of GentleCure. Patients are increasingly drawn to this Medicare-covered, nonsurgical therapy that allows them to maintain their normal routines without interruption. More than 125,000 patients have been treated with GentleCure across 400 dermatology practices, with thousands more receiving treatment each day. Notably, over 70 practices have introduced GentleCure just this year, a clear signal of its growing role in dermatology.  

 

Aaron S. Farberg, M.D., double board-certified dermatologist, Mohs surgeon, and editorial board member for leading medical journals, including Dermatology & Therapy and SKIN, affirms the trend. 

 

“At the five Texas practices for which I serve as Chief Medical Officer, we’ve seen a significant rise in patient demand for this noninvasive option,” Dr. Farberg notes. “While not every case of skin cancer is appropriate for GentleCure, thoughtful consultation with our board certified dermatologists ensures proper use and shared decision-making. For those treated, both the medical outcomes and patient satisfaction have been exceptional.” 

 

GentleCure harnesses Image-Guided Superficial Radiation Therapy (IGSRT), a state-of-the-art combination of technologies designed to treat basal cell and squamous cell carcinomas. 

 

Using low-level x-ray energy, GentleCure destroys cancer cells while sparing healthy tissue. The precision comes from high-resolution dermal ultrasound imaging, which maps the cancer in real time and enables the provider to deliver exactly the right dose. Quick and painless treatment delivery is repeated over several weeks, with minimal impact on a patients’ daily lives. 

 

The therapy’s success is supported by 17 clinical studies, which document cure rates exceeding 99 percent, matched by equally high patient satisfaction scores. 

 

Demographic trends are amplifying the need for noninvasive skin cancer care. As the  population ages and life expectancy rises, the incidence of skin cancer continues to climb, particularly among those with extensive sun exposure. Many older adults also face health conditions that make surgery riskier. 

 

The statistics are sobering: 9,500 Americans are diagnosed with skin cancer each day, adding up to more than 3 million new cases annually. Against this backdrop, GentleCure provides a safe, effective, and patient-friendly alternative that aligns with the realities of modern dermatology care. 

 

The growing adoption of GentleCure reflects a broader cultural and clinical shift toward noninvasive, patient-centered oncology care. As practices continue to embrace this technology, they expand their treatment capabilities and empower patients with choice, comfort, and confidence in their care journey. 

 

For more information, visit GentleCure.com 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.